Recent Sentinel Activity

This recent activity feed provides a list of the last 90 days of Sentinel activity across assessments, publications & presentations, projects, events, etc.

RSS Feed

URL	Title	Category	Date	Recent Activity
https://sentinelinitiative.org/methods-data-tools/methods/covid-19-pregnancy-study-implementation	COVID-19 Pregnancy Study Implementation	Methods, Data, & Tools	02/24/2021	COVID-19 Pregnancy Study Implementation Methods, Data, & Tools 02/24/2021
https://sentinelinitiative.org/methods-data-tools/methods/augmenting-date-death-cause-death-ascertainment-sentinel	Augmenting Date of Death & Cause of Death Ascertainment in Sentinel	Methods, Data, & Tools	03/16/2022	Augmenting Date of Death & Cause of Death Ascertainment in Sentinel Methods, Data, & Tools 03/16/2022
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-medication-use-among-pregnancies-covid-19	Characterizing Medication Use Among Pregnancies with COVID-19 in the Sentinel System	Publications and Presentations	08/26/2022	Characterizing Medication Use Among Pregnancies with COVID-19 in the Sentinel System Publications and Presentations 08/26/2022
https://sentinelinitiative.org/news-events/publications-presentations/systemic-corticosteroids-covid-19-us-outpatient-settings	Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings	Publications and Presentations	08/28/2022	Systemic Corticosteroids for COVID-19 in U.S. Outpatient Settings Publications and Presentations 08/28/2022
https://sentinelinitiative.org/news-events/publications-presentations/describing-prenatal-exposures-and-evaluating-maternal-and	Describing Prenatal Exposures and Evaluating Maternal and Infant Outcomes in Sentinel	Publications and Presentations	09/13/2022	Describing Prenatal Exposures and Evaluating Maternal and Infant Outcomes in Sentinel Publications and Presentations 09/13/2022
https://sentinelinitiative.org/methods-data-tools/methods/onboarding-commercial-electronic-health-record-ehr-data-partners	Onboarding of Commercial Electronic Health Record (EHR) Data Partners	Methods, Data, & Tools	11/01/2022	Onboarding of Commercial Electronic Health Record (EHR) Data Partners Methods, Data, & Tools 11/01/2022
https://sentinelinitiative.org/methods-data-tools/methods/inclusion-semi-structured-and-unstructured-electronic-health-record-ehr	Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment	Methods, Data, & Tools	12/09/2022	Inclusion of Semi-Structured and Unstructured Electronic Health Record (EHR) Data in Confounding Adjustment and Outcome Ascertainment Methods, Data, & Tools 12/09/2022
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characterization-patients-and-encounters-trinetx-live-usa	Characterization of Patients and Encounters in the TriNetX Live USA Network: A Descriptive Analysis	Analyses	01/12/2023	Characterization of Patients and Encounters in the TriNetX Live USA Network: A Descriptive Analysis Analyses 01/12/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-or-linked-infant	Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis	Analyses	03/03/2023	Congenital Malformations Observed in the Mother’s or Linked Infant’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Analyses 03/03/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/congenital-malformations-observed-mother-s-records-following	Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis	Analyses	03/03/2023	Congenital Malformations Observed in the Mother’s Records Following Fingolimod Use During Pregnancy: A Descriptive Analysis Analyses 03/03/2023
https://sentinelinitiative.org/methods-data-tools/methods/creating-sentinel-linked-electronic-health-record-ehr-claims-development	Creating a Sentinel Linked Electronic Health Record (EHR)-claims Development Network	Methods, Data, & Tools	04/18/2023	Creating a Sentinel Linked Electronic Health Record (EHR)-claims Development Network Methods, Data, & Tools 04/18/2023
https://sentinelinitiative.org/studies/drugs/zarxio-filgrastim-sndz	Zarxio (Filgrastim-sndz) & Signal Identification	Studies	06/01/2023	Zarxio (Filgrastim-sndz) & Signal Identification Studies 06/01/2023
https://sentinelinitiative.org/news-events/publications-presentations/characterizing-medication-use-patterns-among-pregnant-and	Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System	Publications and Presentations	08/25/2023	Characterizing Medication Use Patterns Among Pregnant and Non-Pregnant Patients with COVID-19 in the Sentinel System Publications and Presentations 08/25/2023
https://sentinelinitiative.org/news-events/publications-presentations/investigating-potential-differences-safety-profiles	Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic	Publications and Presentations	08/27/2023	Investigating Potential Differences in the Safety Profiles of Biosimilars Relative to Originator Products Using a Tree-Based Scan Statistic Publications and Presentations 08/27/2023
https://sentinelinitiative.org/news-events/publications-presentations/unexpected-issues-pharmacoepidemiology-studies-applying	Unexpected Issues in Pharmacoepidemiology Studies Applying Natural Language Processing to Clinical Notes	Publications and Presentations	10/17/2023	Unexpected Issues in Pharmacoepidemiology Studies Applying Natural Language Processing to Clinical Notes Publications and Presentations 10/17/2023
https://sentinelinitiative.org/studies/drugs/ozempic-semaglutide	Ozempic (Semaglutide) & Signal Identification	Studies	10/25/2023	Ozempic (Semaglutide) & Signal Identification Studies 10/25/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-non-cardiac-congenital-malformations-following	Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis	Analyses	11/13/2023	Risk of Non-Cardiac Congenital Malformations Following Armodafinil or Modafinil Use: A Propensity Score Matched Analysis Analyses 11/13/2023
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/medication-use-among-pregnant-patients-covid-19-descriptive	Medication Use Among Pregnant Patients With COVID-19: A Descriptive Analysis	Analyses	01/11/2024	Medication Use Among Pregnant Patients With COVID-19: A Descriptive Analysis Analyses 01/11/2024
https://sentinelinitiative.org/studies/drugs/angiotensin-converting-enzyme-ace-inhibitors-and-angiotensin-ii-receptor-blockers	Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Signal Identification	Studies	03/18/2024	Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Signal Identification Studies 03/18/2024
https://sentinelinitiative.org/news-events/publications-presentations/targeted-learning-undersmoothed-lasso-propensity-score-model	Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies	Publications and Presentations	03/21/2024	Targeted Learning with an Undersmoothed Lasso Propensity Score Model for Large-Scale Covariate Adjustment in Healthcare Database Studies Publications and Presentations 03/21/2024
https://sentinelinitiative.org/studies/drugs/new-onset-cancer	New-Onset Cancer & Duration of Follow-up	Studies	03/22/2024	New-Onset Cancer & Duration of Follow-up Studies 03/22/2024
https://sentinelinitiative.org/studies/drugs/angiotensin-converting-enzyme-ace-inhibitors-and-angiotensin-ii-receptor-blockers-0	Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Pediatric Drug Utilization	Studies	06/13/2024	Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin II Receptor Blockers (ARBs) & Pediatric Drug Utilization Studies 06/13/2024
https://sentinelinitiative.org/news-events/publications-presentations/use-sentinel-system-examine-medical-product-use-and-outcomes	Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy	Publications and Presentations	06/28/2024	Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy Publications and Presentations 06/28/2024
https://sentinelinitiative.org/studies/drugs/brexafemme-ibrexafungerp	Brexafemme (Ibrexafungerp) & Use in Pregnancy	Studies	07/17/2024	Brexafemme (Ibrexafungerp) & Use in Pregnancy Studies 07/17/2024
https://sentinelinitiative.org/studies/drugs/confounding-conditions	Confounding Conditions & Characterization	Studies	08/01/2024	Confounding Conditions & Characterization Studies 08/01/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-neonatal-health-outcomes-among-pregnant	Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis	Analyses	08/02/2024	Risk of Adverse Neonatal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis Analyses 08/02/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/risk-adverse-maternal-health-outcomes-among-pregnant	Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis	Analyses	08/07/2024	Risk of Adverse Maternal Health Outcomes Among Pregnant Patients With and Without COVID-19: A Propensity Score Matched Analysis Analyses 08/07/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/characteristics-and-drug-utilization-pregnant-patients-covid	Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis	Analyses	08/08/2024	Characteristics and Drug Utilization in Pregnant Patients With COVID-19: A Propensity Score Matched Analysis Analyses 08/08/2024
https://sentinelinitiative.org/news-events/publications-presentations/comparing-risk-adverse-infant-outcomes-among-pregnancies-and	Comparing the Risk of Adverse Infant Outcomes Among Pregnancies with and without COVID-19 in the Sentinel System	Publications and Presentations	08/27/2024	Comparing the Risk of Adverse Infant Outcomes Among Pregnancies with and without COVID-19 in the Sentinel System Publications and Presentations 08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/patterns-prescribing-and-dispensing-medicines-among-non	Patterns of Prescribing and Dispensing Medicines Among Non-Hospitalized Pregnant Women with COVID-19: a Prospective Meta-Analysis Pooling Findings from Healthcare Databases in Europe and North America	Publications and Presentations	08/27/2024	Patterns of Prescribing and Dispensing Medicines Among Non-Hospitalized Pregnant Women with COVID-19: a Prospective Meta-Analysis Pooling Findings from Healthcare Databases in Europe and North America Publications and Presentations 08/27/2024
https://sentinelinitiative.org/news-events/publications-presentations/prenatal-syphilis-us-characterizing-screening-and-treatment	Prenatal Syphilis in the US: Characterizing Screening and Treatment During Pregnancy in Publicly and Commercially Insured Individuals	Publications and Presentations	08/27/2024	Prenatal Syphilis in the US: Characterizing Screening and Treatment During Pregnancy in Publicly and Commercially Insured Individuals Publications and Presentations 08/27/2024
https://sentinelinitiative.org/studies/drugs/individual-drug-analyses/counts-and-characteristics-individuals-prurigo-nodularis-and	Counts and Characteristics of Individuals with Prurigo Nodularis and Other Dermatologic Conditions: A Descriptive Analysis	Analyses	09/03/2024	Counts and Characteristics of Individuals with Prurigo Nodularis and Other Dermatologic Conditions: A Descriptive Analysis Analyses 09/03/2024
https://sentinelinitiative.org/news-events/publications-presentations/fda-sentinel-real-world-evidence-data-enterprise-rwe-de	The FDA Sentinel Real World Evidence Data Enterprise (RWE-DE)	Publications and Presentations	10/10/2024	The FDA Sentinel Real World Evidence Data Enterprise (RWE-DE) Publications and Presentations 10/10/2024
https://sentinelinitiative.org/studies/drugs/aldactone-spironolactone	Aldactone (spironolactone) & Indications for Use	Studies	10/15/2024	Aldactone (spironolactone) & Indications for Use Studies 10/15/2024
https://sentinelinitiative.org/studies/drugs/statins-tumor-necrosis-factor-tnf-alpha-inhibitors-granulocyte-colony-stimulating	Statins, Tumor Necrosis Factor (TNF) Alpha Inhibitors, Granulocyte Colony Stimulating Factors, Intravenous (IV) Iron, Beta Blockers, and Angiotensin-Converting Enzyme (ACE) Inhibitors & Utilization	Studies	10/15/2024	Statins, Tumor Necrosis Factor (TNF) Alpha Inhibitors, Granulocyte Colony Stimulating Factors, Intravenous (IV) Iron, Beta Blockers, and Angiotensin-Converting Enzyme (ACE) Inhibitors & Utilization Studies 10/15/2024
https://sentinelinitiative.org/studies/drugs/enterovirus	Enterovirus & Neonatal Enteroviral Sepsis	Studies	10/15/2024	Enterovirus & Neonatal Enteroviral Sepsis Studies 10/15/2024
https://sentinelinitiative.org/studies/drugs/hydroxyurea	Hydroxyurea & Use by Indication	Studies	10/15/2024	Hydroxyurea & Use by Indication Studies 10/15/2024
https://sentinelinitiative.org/studies/drugs/drugs-risk-evaluation-and-mitigation-strategies-rems-employ-elements-assure-safe-use	Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) & Utilization	Studies	10/16/2024	Drugs with Risk Evaluation and Mitigation Strategies (REMS) That Employ Elements to Assure Safe Use (ETASU) & Utilization Studies 10/16/2024
https://sentinelinitiative.org/studies/drugs/cannabis	Cannabis & Substance Use Disorder and Poisoning	Studies	11/06/2024	Cannabis & Substance Use Disorder and Poisoning Studies 11/06/2024
https://sentinelinitiative.org/studies/drugs/skyrizi-risankizumab-rzaa	Skyrizi (Risankizumab-Rzaa) & Signal Identification	Studies	11/07/2024	Skyrizi (Risankizumab-Rzaa) & Signal Identification Studies 11/07/2024